drugset / Trial / NCT02371031
FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas
NaSingle-groupOpen-labelDiagnostic
Summary
This is a pilot study designed to evaluate the potential of using FDOPA-PET/MRI for improving surgical planning and providing non-invasive prognostic information in patients with gliomas that have substantial non-enhancing regions. The results will be used to develop larger adequately powered studies.
Timeline
- Start
- 2015-03
- Primary completion
- 2016-07
- Completion
- 2016-07
Outcome
Outcome not reported
Stopped (Business): “Funding source for study ended.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 6-[F-18]-Fluoro-L-3,4,-dihydroxyphenylalanine | Diagnostic / imaging agent | — | — |